LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) 2.8 million injections of repackaged off-label bevacizumab in Europe each year 1 ISELIN, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that LYTENAVA™ (bevacizumab gamma) is now commercially available in Germany and the UK for the treatment of wet age-related macular degeneration (wet AMD).
Nvidia Corporation's strong outlook and favorable tariff ruling has boosted semiconductor sentiment, mitigating China headwinds and supporting sector resilience. Advanced Micro Devices, Inc.'s Q1 results and ongoing data center momentum reinforce confidence in its core business, despite cyclical and competitive challenges. AI growth remains AMD's key catalyst; upcoming investor day is crucial for management to clarify long-term AI revenue outlook and drive re-rating.
Nvidia (NASDAQ: NVDA ) has just reported no less than $44.06 billion in revenue for the previous quarter and is up 6% premarket.
![]() AMD 27 Apr 1995 Paid | Annual | $0.01 Per Share |
28 Jul 2025 (55 Days) Date | | - Cons. EPS | - EPS |
6 May 2025 Date | | - Cons. EPS | 0.41 EPS |
28 Apr 2025 Date | | - Cons. EPS | - EPS |
28 Jan 2025 Date | | - Cons. EPS | - EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.43 EPS |
![]() AMD 27 Apr 1995 Paid | Annual | $0.01 Per Share |
28 Jul 2025 (55 Days) Date | | - Cons. EPS | - EPS |
6 May 2025 Date | | - Cons. EPS | 0.41 EPS |
28 Apr 2025 Date | | - Cons. EPS | - EPS |
28 Jan 2025 Date | | - Cons. EPS | - EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.43 EPS |
Semiconductors Industry | Technology Sector | Dr. Lisa T. Su Ph.D. CEO | XETRA Exchange | US0079031078 ISIN |
US Country | 28,000 Employees | - Last Dividend | 22 Aug 2000 Last Split | 15 Oct 1979 IPO Date |
Advanced Micro Devices, Inc. (AMD) stands as a global semiconductor company, distinguishing itself through its operations across several key sectors: Data Center, Client, Gaming, and Embedded. With a comprehensive portfolio that includes x86 microprocessors, graphics processing units (GPUs), system-on-chip (SoC) solutions, and an array of development services and technologies, AMD caters to a diverse clientele. This includes original equipment and design manufacturers, public cloud service providers, and independent distributors. Since its incorporation in 1969, AMD has established its headquarters in Santa Clara, California, reflecting the company’s enduring commitment to innovation and excellence in the semiconductor industry.
AMD’s expansive product line is designed to meet the increasing demands of modern technology applications, ranging from consumer computing to professional data centers. Here is an overview of its key offerings:
AMD serves its varied product portfolio to a global clientele through a composite of direct sales forces and sales representatives, highlighting the company's wide-reaching impact on modern computing, gaming, data centers, and embedded technologies.